SGLT-2抑制剂可降低心血管死亡率，但益处有限，即使在已确诊心脏病的患者中也是如此

{"title":"SGLT-2抑制剂可降低心血管死亡率，但益处有限，即使在已确诊心脏病的患者中也是如此","authors":"Mark H Ebell","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7713,"journal":{"name":"American family physician","volume":"111 1","pages":"84"},"PeriodicalIF":3.8000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"SGLT-2 Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest, Even in Patients With Established Heart Disease.\",\"authors\":\"Mark H Ebell\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7713,\"journal\":{\"name\":\"American family physician\",\"volume\":\"111 1\",\"pages\":\"84\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American family physician\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American family physician","FirstCategoryId":"3","ListUrlMain":"","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}